project id: TCGA-LUAD; case submitter id: TCGA-05-4245; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 81; days to birth: -29647; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1928; age at diagnosis: 29647; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 730.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.7534246575342465; pack years smoked: 32.0; is ffpe: false; portion number: 01; weight: 168.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-05-4245-01A-01; percent lymphocyte infiltration: 2.0; percent necrosis: 15.0; percent normal cells: 10.0;